Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$117.13 - $176.59 $819 - $1,236
-7 Reduced 12.5%
49 $7,000
Q1 2022

May 05, 2022

BUY
$126.46 - $235.05 $1,264 - $2,350
10 Added 21.74%
56 $9,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $1,806 - $2,948
8 Added 21.05%
46 $12,000
Q3 2021

Nov 08, 2021

BUY
$221.9 - $484.47 $221 - $484
1 Added 2.7%
38 $15,000
Q2 2021

Jul 29, 2021

SELL
$129.91 - $234.98 $2,468 - $4,464
-19 Reduced 33.93%
37 $9,000
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $4,367 - $7,439
-40 Reduced 41.67%
56 $7,000
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $6,311 - $16,306
96 New
96 $10,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Charter Oak Capital Management, LLC Portfolio

Follow Charter Oak Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Charter Oak Capital Management, LLC with notifications on news.